Left ventricular reverse remodelling, long-term clinical outcome, and mode of death after cardiac resynchronization therapy

European Journal of Heart Failure

Volumn 13, Issue 1, 2011, Pages 43-51

  Foley, Paul W X ^a   Chalil, Shajil ^a   Khadjooi, Kayvan ^b   Irwin, Nick ^b   Smith, Russell E A ^a   Leyva, Francisco ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cardiac resynchronization therapy; Echocardiography; Heart failure; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE VOLUME; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

AGED; ANALYSIS OF VARIANCE; CARDIAC PACING, ARTIFICIAL; CONFIDENCE INTERVALS; DISEASE PROGRESSION; FEMALE; GREAT BRITAIN; HEART FAILURE; HEART VENTRICLES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 78650406963     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq182     Document Type: Article

References (39)

1. Dickstein K Cohen-Solal A Filippatos G McMurray JJ Ponikowski P Poole-Wilson PA Stromberg A van Veldhuisen DJ Atar D Hoes AW Keren A Mebazaa A Nieminen M Priori SG Swedberg K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
2. van Veldhuisen DJ Maass AH Priori SG Stolt P van Gelder IC Dickstein K Swedberg K. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail 2009;11: 1143-1151.
3. Gaudron P Eilles C Kugler I Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Potential mechanisms and early predictors. Circulation 1993;87:755-763.
4. White HD Norris RM Brown MA Brandt PW Whitlock RM Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
5. Konstam MA Kronenberg MW Rousseau MF Udelson JE Melin J Stewart D Doaln N Edens TS Ahn S Kinan D. Effects of the angiotensin-converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic left ventricular dysfunction. Ciculation 1993;88: 2277-2283.
6. Groenning BA Nilsson JC Sondergaard L Fritz-Hansen T Larsson HB Hildebrandt PR. Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. J Am Coll Cardiol 2000; 36:2072-2080.
7. Yu CM Bleeker GB Fung JW Schalij MJ Zhang Q van der Wall EE Chan YS Kong SL Bax JJ. Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation 2005;112:1580-1586.
8. Ypenburg C van Bommel RJ Borleffs CJ Bleeker GB Boersma E Schalij MJ Bax JJ. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up. J Am Coll Cardiol 2009;53:483-490.
9. van Bommel RJ Bax JJ Abraham WT Chung ES Pires LA Tavazzi L Zimetbaum PJ Gerritse B Kristiansen N Ghio S. Characteristics of heart failure patients associated with good and poor response to cardiac resynchroniza-tion therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J 2009;30:2470-2477.
10. Marsan NA Bleeker GB van Bommel RJ Ypenburg C Delgado V Borleffs CJ Holman ER van der Wall EE Schalij MJ Bax JJ. Comparison of time course of response to cardiac resynchronization therapy in patients with ischemic versus nonischemic cardiomyopathy. Am J Cardiol 2009;103:690-694.
11. Markowitz SM Lewen JM Wiggenhorn CJ Abraham WT Stein KM Iwai S Lerman BB. Relationship of reverse anatomical remodeling and ventricular arrhythmias after cardiac resynchronization. J Cardiovasc Electrophysiol 2009;20: 293-298.
12. Knebel F Schattke S Bondke H Richter C Melzer C Dreger H Grohmann A Baumann G Borges AC. Implementation of seven echocardiographic parameters of myocardial asynchrony to improve the long-term response rate of cardiac resynchronization therapy (CRT). Cardiovasc Ultrasound 2008;6:58.
13. Kirn B Jansen A Bracke F van Gelder B Arts T Prinzen FW. Mechanical discoor-dination rather than dyssynchrony predicts reverse remodeling upon cardiac resynchronization. Am J Physiol Heart Circ Physiol 2008;295:H640-H646.
14. Guyatt GH Sullivan MJ Thompson PJ. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985; 132:919-923.
15. Alpert JS Thygesen K Antman E Bassand JP. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969.
16. Assomull RG Prasad SK Lyne J Smith G Burman ED Khan M Sheppard MN Poole-Wilson PA Pennell DJ. Cardiovascular magnetic resonance fibrosis and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977-1985.
17. Ritter P Padeletti L Gillio-Meina L Gaggini G. Determination of the optimal atrioventricular delay in DDD pacing: Comparison between echo and peak endo-cardial acceleration measurements. Europace 1999;1:126-130.
18. Schiller NB Shah PM Crawford M DeMaria A Devereux R Feigenbaum H Gutgesell H Reichek N Sahn D Schnittger I et al. Recommendations for quanti-tation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards Subcommittee on Quan-titation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2: 358-367
19. Myerburg RJ Castellanos A. Cardiac arrest and sudden cardiac death. In: Braunwald E ed. Heart Disease: A Textbook of Cardiovascular Medicine. New York: WB Saunders Publishing Co; 1997. p.742-779.
20. Rockman HA Juneau C Chatterjee K Rouleau JL. Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1989;64:1344-1348.
21. Cleland JGF Daubert J-C Erdmann E Freemantle N Gras D Kappenberger L Tavazzi L. for the Cardiac Resynchronization-Heart Failure (CARE-HF) study investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Eng J Med 2005;352:1539-1549. (Pubitemid 40517094)
22. St John Sutton MG Plappert T Abraham WT Smith AL DeLurgio DB Leon AR Loh E Kocovic DZ Fisher WG Ellestad M Messenger J Kruger K Hilpisch KE Hill MRS for the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003;107:1985-1990.
23. Bax JJ Bleeker GB Marwick TH Molhoek SG Boersma E Steendijk P Van der Wall EE Schalij MJ. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Col Cardiol 2004;44:1834-1840.
24. Lafitte S Reant P Zaroui A Donal E Mignot A Bougted H Belghiti H Bordachar P Deplagne A Chabaneix J Franceschi F Deharo JC Santos PD Clementy J Roudaut R Leclercq C Habib G. Validation of an echocardiographic multiparametric strategy to increase responders patients after cardiac resynchro-nization: a multicentre study. Eur Heart J 2009;30:2880-2887.
25. Chung E Leon A Tavazzi L Sun J Nihoyannopoulos P Merlino J Abraham W Guio S Leclerq C Bax J Yu C-M Gorcsan J III Sutton M De Sutter J Murillo J. Results of the Predictors of Response to CRT (PROSPECT) Trial. Circulation 2008;117:2608-2616.
26. Di Biase L Gasparini M Lunati M Santini M Landolina M Boriani G Curnis A Bocchiardo M Vincenti A Denaro A Valsecchi S Natale A Padeletti L. Anti-arrhythmic effect of reverse ventricular remodeling induced by cardiac resynchro-nization therapy: the InSync ICD (Implantable Cardioverter- Defibrillator) Italian Registry. J Am Coll Cardiol 2008;52:1442-1449.
27. Narang R Cleland JG Erhardt L Ball SG Coats AJ Cowley AJ Dargie HJ Hall AS Hampton JR Poole-Wilson PA. Mode of death in chronic heart failure. A request and proposition for more accurate classification. Eur Heart J 1996;17:1390-1403.
28. Bleasdale RA Turner MS Mumford CE Steendijk P Paul V Tyberg JV Morris-Thurgood JA Frenneaux MP. Left ventricular pacing minimizes diastolic ventricular interaction allowing improved preload-dependent systolic performance. Circulation 2004;110:2395-2400.
29. Ypenburg C Lancellotti P Tops LF Bleeker GB Holman ER Pierard LA Schalij MJ Bax JJ. Acute effects of initiation and withdrawal of cardiac resynchro-nization therapy on papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol 2007;50:2071-2077.
30. Sadeghpour A Abtahi F Kiavar M Esmaeilzadeh M Samiei N Ojaghi SZ Bakhshandeh H Maleki M Noohi F Mohebbi A. Echocardiographic evaluation of mitral geometry in functional mitral regurgitation. J CardiothoracSurg 2008;3:54.
31. Cazeau S Leclercq C Lavergene T Walker S Varma C Linde C Garrigue S Kappenberger L Haywood GA Santini M Bailleul C Daubert J-C for the Multi-stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multi-site biventricular pacing in patients with heart failure and interventricular conduction delay. N Engl J Med 2001;344:873-880.
32. Moss AJ Hall WJ Cannom DS Klein H Brown MW Daubert JP Estes NA 3rd Foster E Greenberg H Higgins SL Pfeffer MA Solomon SD Wilber D Zareba W. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-1338.
33. St John Sutton M Ghio S Plappert T Tavazzi L Scelsi L Daubert C Abraham WT Gold MR Hassager C Herre JM Linde C. Cardiac resynchroniza-tion induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure. Circulation 2009;120: 1858-1865.
34. Lubitz SA Leong-Sit P Fine N Kramer DB Singh J Ellinor PT. Effectiveness of cardiac resynchronization therapy in mild congestive heart failure: systematic review and meta-analysis of randomized trials. Eur J Heart Fail 2009;12: 360-366.
35. Gasparini M Auricchio A Regoli F Fantoni C Kawbata M Galimberri P Pini D Ceriotti C Gronda E Klersy C Fratini S Klein HH. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression. J Am Coll Cardiol 2006;48:734-743.
36. Khadjooi K Foley P Chalil S Anthony J Smith R Frenneaux M Leyva F. Long-term effects of cardiac resynchronisation therapy in patients with atrial fibrillation. Heart 2008;:879-883.
37. Kies P Leclercq C Bleeker GB Crocq C Molhoek SG Poulain C van Erven L Bootsma M Zeppenfeld K van der Wall EE Daubert JC Schalij MJ Bax JJ. Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm. Heart 2006;92:490-494.
38. Woo GW Petersen-Stejskal S Johnson JW Conti JB Aranda JA Jr Curtis AB. Ventricular reverse remodeling and 6-month outcomes in patients receiving cardiac resynchronization therapy: analysis of the MIRACLE study. J Interv Card Electrophysiol 2005;12:107-113.
39. Jenkins C Bricknell K Chan J Hanekom L Marwick T. Comparison of two- and three-dimensional echocardiography with sequential magnetic resonance imaging for evaluating left ventricular volume and ejection fraction over time in patients with healed myocardial infarction. Am J Cardiol 2007;99:300-306.